Filing Details
- Accession Number:
- 0001209191-21-006310
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-29 19:59:34
- Reporting Period:
- 2021-01-27
- Accepted Time:
- 2021-01-29 19:59:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326110 | Nantkwest Inc. | NK | Biological Products, (No Disgnostic Substances) (2836) | 431979754 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647994 | J. Barry Simon | C/O Nantkwest, Inc. 3530 John Hopkins Court San Diego CA 92121 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-27 | 36,626 | $2.00 | 3,207,166 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-27 | 36,626 | $20.61 | 3,170,540 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-28 | 11,304 | $2.00 | 3,181,844 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-28 | 11,304 | $20.53 | 3,170,540 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-27 | 36,626 | $0.00 | 36,626 | $2.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-28 | 11,304 | $0.00 | 11,304 | $2.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 225,494 | 2025-02-16 | No | 4 | M | Direct | |
| 214,190 | 2025-02-16 | No | 4 | M | Direct |
Footnotes
- The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 12, 2019.
- Represents the weighted average share price of an aggregate total of 36,626 shares sold in the price range of $20.50 to $20.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 11,304 shares sold in the price range of $20.50 to $20.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is January 16, 2015.
Billionaire Hedge Funds
